Head and Neck Cancer

 

Erlotinib + Cisplatin/Radiotherapy (6106)
A Multicenter Randomized Phase II Study of Erlotinib (Tarceva), Cisplatin and Radiotherapy Versus Cisplatin and Radiotherapy in Patients With Stage III and IV Squamous Cell Carcinoma of the Head and Neck

Investigator: Renato G. Martins, MD, MPH;   Conditions: Head and Neck Cancer;    Status: Recruiting;   Study ID: NCT00410826